View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsGenerix 향후 성장Future 기준 점검 1/6핵심 정보n/a이익 성장률21.33%EPS 성장률Software 이익 성장8.3%매출 성장률6.4%향후 자기자본이익률9.30%애널리스트 커버리지Low마지막 업데이트n/a최근 향후 성장 업데이트공시 • Dec 10Generix Group Provides Revenue Guidance for Fiscal Year 2021Generix Group provided revenue guidance for fiscal year 2021. For the year, the company expects its revenue growth to be a few points lower than the double-digit growth previously expected, but nevertheless higher than the pre-crisis revenue for fiscal 2019-2020.Major Estimate Revision • Jun 10Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.19 to €0.24. Revenue forecast unchanged at €88.0m. Net income forecast to grow 6.0% next year vs 24% growth forecast for Software industry in France. Consensus price target up from €8.50 to €9.00. Share price was steady at €9.36 over the past week.Price Target Changed • Jun 03Price target increased to €9.00Up from €8.00, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of €9.32. Stock is up 43% over the past year.모든 업데이트 보기Recent updatesRecent Insider Transactions • Jul 27Insider recently bought €70k worth of stockOn the 22nd of July, Jean-Luc Barma bought around 7k shares on-market at roughly €9.58 per share. In the last 3 months, they made an even bigger purchase worth €79k. Insiders have collectively bought €223k more in shares than they have sold in the last 12 months.Recent Insider Transactions • Jul 08Insider recently bought €79k worth of stockOn the 1st of July, Jean-Luc Barma bought around 8k shares on-market at roughly €9.56 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Reported Earnings • Jun 10Full year 2022 earnings: Revenues in line with analyst expectationsFull year 2022 results: Revenue: €84.5m (up 5.3% from FY 2021). Net income: €3.40m (down 32% from FY 2021). Profit margin: 4.0% (down from 6.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 6.5%, compared to a 12% growth forecast for the industry in France.분석 기사 • Apr 29Returns On Capital Are Showing Encouraging Signs At Generix (EPA:GENX)What are the early trends we should look for to identify a stock that could multiply in value over the long term...분석 기사 • Mar 30A Look At The Fair Value Of Generix SA (EPA:GENX)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Generix SA ( EPA:GENX...Buying Opportunity • Mar 07Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 41%. The fair value is estimated to be €7.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% per annum over the last 3 years. Earnings per share has grown by 41% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €6.22, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 29x in the Software industry in France. Total returns to shareholders of 61% over the past three years.공시 • Dec 10Generix Group Provides Revenue Guidance for Fiscal Year 2021Generix Group provided revenue guidance for fiscal year 2021. For the year, the company expects its revenue growth to be a few points lower than the double-digit growth previously expected, but nevertheless higher than the pre-crisis revenue for fiscal 2019-2020.Major Estimate Revision • Jun 10Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.19 to €0.24. Revenue forecast unchanged at €88.0m. Net income forecast to grow 6.0% next year vs 24% growth forecast for Software industry in France. Consensus price target up from €8.50 to €9.00. Share price was steady at €9.36 over the past week.Reported Earnings • Jun 05Full year 2021 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: €80.3m (down 1.0% from FY 2020). Net income: €5.00m (up 47% from FY 2020). Profit margin: 6.2% (up from 4.2% in FY 2020).Price Target Changed • Jun 03Price target increased to €9.00Up from €8.00, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of €9.32. Stock is up 43% over the past year.분석 기사 • May 04Generix (EPA:GENX) Has More To Do To Multiply In Value Going ForwardIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...분석 기사 • Mar 08What Kind Of Investors Own Most Of Generix SA (EPA:GENX)?Every investor in Generix SA ( EPA:GENX ) should be aware of the most powerful shareholder groups. Institutions will...분석 기사 • Feb 15Is Generix's (EPA:GENX) 194% Share Price Increase Well Justified?When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...분석 기사 • Jan 27Does Generix (EPA:GENX) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Is New 90 Day High Low • Jan 13New 90-day high: €8.06The company is up 6.0% from its price of €7.60 on 14 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is up 5.0% over the same period.분석 기사 • Jan 09Here's What To Make Of Generix's (EPA:GENX) Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Dec 22Does Generix's (EPA:GENX) Statutory Profit Adequately Reflect Its Underlying Profit?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...Reported Earnings • Dec 12First half 2021 earnings released: EPS €0.09The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: €38.1m (down 4.4% from 1H 2020). Net income: €2.05m (down 43% from 1H 2020). Profit margin: 5.4% (down from 8.9% in 1H 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Analyst Estimate Surprise Post Earnings • Dec 12Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 32%. Over the next year, revenue is forecast to grow 2.7%, compared to a 7.9% growth forecast for the Software industry in France.분석 기사 • Dec 07Could The Market Be Wrong About Generix SA (EPA:GENX) Given Its Attractive Financial Prospects?With its stock down 6.6% over the past three months, it is easy to disregard Generix (EPA:GENX). But if you pay close...분석 기사 • Nov 19What Is Generix SA's (EPA:GENX) Share Price Doing?Generix SA (EPA:GENX), is not the largest company out there, but it saw significant share price movement during recent...Valuation Update With 7 Day Price Move • Nov 02Market pulls back on stock over the past weekAfter last week's 17% share price decline to €6.52, the stock is trading at a trailing P/E ratio of 42.8x, down from the previous P/E ratio of 51.5x. This compares to an average P/E of 64x in the Software industry in France. Total returns to shareholders over the past three years are 129%.Valuation Update With 7 Day Price Move • Oct 29Market pulls back on stock over the past weekAfter last week's 16% share price decline to €6.56, the stock is trading at a trailing P/E ratio of 43.1x, down from the previous P/E ratio of 51.2x. This compares to an average P/E of 64x in the Software industry in France. Total returns to shareholders over the past three years are 129%.Is New 90 Day High Low • Oct 26New 90-day high: €7.84The company is up 9.0% from its price of €7.22 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is flat over the same period.이익 및 매출 성장 예측ENXTPA:GENX - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/202496N/A7813/31/202390N/A5713/31/2022853812N/A3/31/2021804812N/A12/31/2020803812N/A9/30/2020792812N/A6/30/2020803812N/A3/31/2020813711N/A12/31/2019804710N/A9/30/2019795810N/A6/30/201978457N/A3/31/201977235N/A12/31/201875113N/A9/30/2018730-11N/A6/30/201872102N/A3/31/201870113N/A12/31/201769035N/A9/30/201768046N/A6/30/201765035N/A3/31/201763014N/A12/31/2016620-22N/A9/30/2016611-40N/A6/30/2016601-30N/A3/31/2016581-30N/A12/31/2015572N/A-1N/A9/30/2015563N/A-2N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: GENX 의 예상 수익 증가율이 절약률(0.3%)보다 높은지 판단하기에는 데이터가 부족합니다.수익 vs 시장: GENX 의 수익이 French 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 수익: GENX 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.수익 대 시장: GENX 의 수익(연간 6.4%)이 French 시장(연간 5.7%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: GENX 의 수익(연간 6.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: GENX의 자본 수익률은 3년 후 9.3%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YSoftware 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/09/13 08:15종가2022/08/23 00:00수익2022/03/31연간 수익2022/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Generix SA는 4명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jean Pascal BrivadyCIC Market Solutions (ESN)Emmanuel MatotODDO BHF Corporate & MarketsMatthias DesmaraisODDO BHF Corporate & Markets1명의 분석가 더 보기
공시 • Dec 10Generix Group Provides Revenue Guidance for Fiscal Year 2021Generix Group provided revenue guidance for fiscal year 2021. For the year, the company expects its revenue growth to be a few points lower than the double-digit growth previously expected, but nevertheless higher than the pre-crisis revenue for fiscal 2019-2020.
Major Estimate Revision • Jun 10Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.19 to €0.24. Revenue forecast unchanged at €88.0m. Net income forecast to grow 6.0% next year vs 24% growth forecast for Software industry in France. Consensus price target up from €8.50 to €9.00. Share price was steady at €9.36 over the past week.
Price Target Changed • Jun 03Price target increased to €9.00Up from €8.00, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of €9.32. Stock is up 43% over the past year.
Recent Insider Transactions • Jul 27Insider recently bought €70k worth of stockOn the 22nd of July, Jean-Luc Barma bought around 7k shares on-market at roughly €9.58 per share. In the last 3 months, they made an even bigger purchase worth €79k. Insiders have collectively bought €223k more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Jul 08Insider recently bought €79k worth of stockOn the 1st of July, Jean-Luc Barma bought around 8k shares on-market at roughly €9.56 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Reported Earnings • Jun 10Full year 2022 earnings: Revenues in line with analyst expectationsFull year 2022 results: Revenue: €84.5m (up 5.3% from FY 2021). Net income: €3.40m (down 32% from FY 2021). Profit margin: 4.0% (down from 6.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 6.5%, compared to a 12% growth forecast for the industry in France.
분석 기사 • Apr 29Returns On Capital Are Showing Encouraging Signs At Generix (EPA:GENX)What are the early trends we should look for to identify a stock that could multiply in value over the long term...
분석 기사 • Mar 30A Look At The Fair Value Of Generix SA (EPA:GENX)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Generix SA ( EPA:GENX...
Buying Opportunity • Mar 07Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 41%. The fair value is estimated to be €7.48, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% per annum over the last 3 years. Earnings per share has grown by 41% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €6.22, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 29x in the Software industry in France. Total returns to shareholders of 61% over the past three years.
공시 • Dec 10Generix Group Provides Revenue Guidance for Fiscal Year 2021Generix Group provided revenue guidance for fiscal year 2021. For the year, the company expects its revenue growth to be a few points lower than the double-digit growth previously expected, but nevertheless higher than the pre-crisis revenue for fiscal 2019-2020.
Major Estimate Revision • Jun 10Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate increased from €0.19 to €0.24. Revenue forecast unchanged at €88.0m. Net income forecast to grow 6.0% next year vs 24% growth forecast for Software industry in France. Consensus price target up from €8.50 to €9.00. Share price was steady at €9.36 over the past week.
Reported Earnings • Jun 05Full year 2021 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: €80.3m (down 1.0% from FY 2020). Net income: €5.00m (up 47% from FY 2020). Profit margin: 6.2% (up from 4.2% in FY 2020).
Price Target Changed • Jun 03Price target increased to €9.00Up from €8.00, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of €9.32. Stock is up 43% over the past year.
분석 기사 • May 04Generix (EPA:GENX) Has More To Do To Multiply In Value Going ForwardIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
분석 기사 • Mar 08What Kind Of Investors Own Most Of Generix SA (EPA:GENX)?Every investor in Generix SA ( EPA:GENX ) should be aware of the most powerful shareholder groups. Institutions will...
분석 기사 • Feb 15Is Generix's (EPA:GENX) 194% Share Price Increase Well Justified?When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
분석 기사 • Jan 27Does Generix (EPA:GENX) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Is New 90 Day High Low • Jan 13New 90-day high: €8.06The company is up 6.0% from its price of €7.60 on 14 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is up 5.0% over the same period.
분석 기사 • Jan 09Here's What To Make Of Generix's (EPA:GENX) Returns On CapitalFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Dec 22Does Generix's (EPA:GENX) Statutory Profit Adequately Reflect Its Underlying Profit?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Reported Earnings • Dec 12First half 2021 earnings released: EPS €0.09The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: €38.1m (down 4.4% from 1H 2020). Net income: €2.05m (down 43% from 1H 2020). Profit margin: 5.4% (down from 8.9% in 1H 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Analyst Estimate Surprise Post Earnings • Dec 12Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 32%. Over the next year, revenue is forecast to grow 2.7%, compared to a 7.9% growth forecast for the Software industry in France.
분석 기사 • Dec 07Could The Market Be Wrong About Generix SA (EPA:GENX) Given Its Attractive Financial Prospects?With its stock down 6.6% over the past three months, it is easy to disregard Generix (EPA:GENX). But if you pay close...
분석 기사 • Nov 19What Is Generix SA's (EPA:GENX) Share Price Doing?Generix SA (EPA:GENX), is not the largest company out there, but it saw significant share price movement during recent...
Valuation Update With 7 Day Price Move • Nov 02Market pulls back on stock over the past weekAfter last week's 17% share price decline to €6.52, the stock is trading at a trailing P/E ratio of 42.8x, down from the previous P/E ratio of 51.5x. This compares to an average P/E of 64x in the Software industry in France. Total returns to shareholders over the past three years are 129%.
Valuation Update With 7 Day Price Move • Oct 29Market pulls back on stock over the past weekAfter last week's 16% share price decline to €6.56, the stock is trading at a trailing P/E ratio of 43.1x, down from the previous P/E ratio of 51.2x. This compares to an average P/E of 64x in the Software industry in France. Total returns to shareholders over the past three years are 129%.
Is New 90 Day High Low • Oct 26New 90-day high: €7.84The company is up 9.0% from its price of €7.22 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is flat over the same period.